about
Risk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015.Acceleration of diabetic-wound healing with PEGylated rhaFGF in healing-impaired streptozocin diabetic rats.Charcot osteoarthropathy in diabetes: A brief review with an emphasis on clinical practicePolyherbal formulation as a therapeutic option to improve wound healing in the diabetic footalpha-Lipoic acid modulates extracellular matrix and angiogenesis gene expression in non-healing wounds treated with hyperbaric oxygen therapyThe diabetic foot: a global threat and a huge challenge for GreeceBenefit-risk assessment of becaplermin in the treatment of diabetic foot ulcers.The role of hyperbaric oxygen in the treatment of diabetic foot ulcers.Prediabetic neuropathy: does it exist?The role of nerve growth factor in the prophylaxis and treatment of diabetic foot ulcersEndovascular treatment of critical ischemia in the diabetic foot: new thresholds, new anatomies.Corneal confocal microscopy: a new technique for early detection of diabetic neuropathy.Etiology, pathophysiology and classifications of the diabetic Charcot footNew vistas in the diagnosis of diabetic polyneuropathy.Efficacy of α-lipoic acid in diabetic neuropathy.Local antibiotic delivery systems in diabetic foot osteomyelitis: time for one step beyond?(18)F-FDG PET and PET/CT for the diagnosis of diabetic foot osteomyelitis.Diabetic foot amputations in Greece: where do we go from here?Current achievements with topical negative pressure to improve wound healing in dehiscent ischemic stumps of diabetic patients: a case series.Tissue and swab culture in diabetic foot infections: neuropathic versus neuroischemic ulcers.
P2860
Q33583001-CB549750-4F36-44C8-9782-BE265D7AAD15Q34076711-E24423A2-499F-4297-8240-55F6BAD918A2Q35048068-57022B0E-DC24-485E-9729-EE76F1B695ABQ35234555-804EA3D6-8298-4B85-95E4-422A30BF4408Q36262572-CEE60CC9-67C3-49E5-A4A5-7B7721C6615DQ37418955-50465428-E966-47F6-9973-CE85AF506BA9Q37756899-C18E6C82-7E6C-4B19-A456-29088D0EFD5BQ37923225-385B5C0F-A978-46A7-9180-530A32CF8E87Q38007899-9D052D84-5E90-4E6E-B7B8-8C53085CF16CQ38038613-A70F8DEC-0BED-4DFC-B382-77A63202410FQ38058074-EB16B026-CD05-48FB-96F3-C521A1BC3DBBQ38105996-82034B06-6AE6-46B7-8350-B7FE2E50D297Q38109166-ACF1B285-08BE-457A-8DF7-B72132B1A96EQ38212657-EAD78D15-21FB-4ABB-83A3-873D870BFC08Q38266297-9E0C6035-3570-49E1-8AE0-026EA5611490Q38325417-3C82AD84-AC7B-469A-9C63-0D338483018BQ42546506-97443794-B75E-4A72-BEF4-DA8D635BBD0CQ43725474-6F067326-C831-4A6F-B817-6E21F7DE0AF3Q44255007-75FDDC25-D71A-4B50-AF47-12A694572CB4Q45189582-DA0F4F9B-457B-4CB7-A092-E0A8869E5CC1
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The diabetic foot: established and emerging treatments.
@en
type
label
The diabetic foot: established and emerging treatments.
@en
prefLabel
The diabetic foot: established and emerging treatments.
@en
P2860
P356
P1433
P1476
The diabetic foot: established and emerging treatments.
@en
P2093
P2860
P304
P356
10.1179/ACB.2007.037
P577
2007-07-01T00:00:00Z